| Title | Cancer Nanotechnology |
| Abbreviation | Cancer Nanotechnol. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Biomedical Engineering (Q2); Pharmaceutical Science (Q2); Physical and Theoretical Chemistry (Q2); Oncology (Q3) |
| h-index | 36 |
| Overall Rank/Ranking | 7867 |
| SCImago Journal Rank (SJR) | 0.671 |
| Impact Score | 4.21 |
| Publisher | Springer Science + Business Media |
| Country | United States |
| ISSN | 18686958, 18686966 |
| Best Quartile | Q2 |
| Coverage History | 2010-2023 |
Cancer Nanotechnology is a journal covering the technologies/fields/categories related to Biomedical Engineering (Q2); Pharmaceutical Science (Q2); Physical and Theoretical Chemistry (Q2); Oncology (Q3). It is published by Springer Science + Business Media. The overall rank of Cancer Nanotechnology is 7867. According to SCImago Journal Rank (SJR), this journal is ranked 0.671. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 36. The best quartile for this journal is Q2.
The ISSN of Cancer Nanotechnology journal is 18686958, 18686966. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Cancer Nanotechnology is cited by a total of 399 articles during the last 3 years (Preceding 2023).
The Impact IF 2023 of Cancer Nanotechnology is 4.21, which is computed in 2024 as per its definition. Cancer Nanotechnology IF is decreased by a factor of 0.64 and approximate percentage change is -13.2% when compared to preceding year 2022, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2023 of Cancer Nanotechnology is 4.21. If the same downward trend persists, Impact IF may fall in 2024 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 4.21 |
| 2022 | 4.85 |
| 2021 | 7.31 |
| 2020 | 4.86 |
| 2019 | 4.95 |
| 2018 | 5.81 |
| 2017 | 3.29 |
| 2016 | 5.64 |
| 2015 | 1.91 |
| 2014 | 2.00 |
Cancer Nanotechnology has an h-index of 36. It means 36 articles of this journal have more than 36 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Cancer Nanotechnology is 18686958, 18686966. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Cancer Nanotechnology is 7867. According to SCImago Journal Rank (SJR), this journal is ranked 0.671. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 0.671 |
| 2022 | 0.882 |
| 2021 | 0.921 |
| 2020 | 0.889 |
| 2019 | 1.299 |
| 2018 | 1.220 |
| 2017 | 1.168 |
| 2016 | 0.875 |
| 2015 | 0.623 |
| 2014 | 0.529 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 7867 |
| 2022 | 5129 |
| 2021 | 4636 |
| 2020 | 5224 |
| 2019 | 2868 |
| 2018 | 3237 |
| 2017 | 3469 |
| 2016 | 5229 |
| 2015 | 7619 |
| 2014 | 8557 |
Cancer Nanotechnology is published by Springer Science + Business Media. It's publishing house is located in United States. Coverage history of this journal is as following: 2010-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Cancer Nanotechnology is Cancer Nanotechnol.. This abbreviation ('Cancer Nanotechnol.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Biomedical Engineering (Q2); Pharmaceutical Science (Q2); Physical and Theoretical Chemistry (Q2); Oncology (Q3), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Cancer Nanotechnology latest impact IF is 4.21. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 7.31 (2021) and 1.91 (2015), respectively, in the last 10 years. Moreover, its average IS is 4.48 in the previous 10 years.
The Cancer Nanotechnology has an SJR (SCImago Journal Rank) of 0.671, according to the latest data. It is computed in the year 2024. In the past 10 years, this journal has recorded a range of SJR, with the highest being 1.299 in 2019 and the lowest being 0.529 in 2014. Furthermore, the average SJR of the Cancer Nanotechnology over the previous 10-year period stands at 4.48.
The latest h-index of the Cancer Nanotechnology is 36.
The Cancer Nanotechnology is published by the Springer Science + Business Media, with its country of publication being the United States.
The Cancer Nanotechnology is currently ranked 7867 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 10 years, this journal has experienced varying rankings, reaching its highest position of 2868 in 2019 and its lowest position of 8557 in 2014.
The standard ISO4 abbreviation for the Cancer Nanotechnology is Cancer Nanotechnol..
Cancer Nanotechnology is classified as a journal that the Springer Science + Business Media publishes.
The Cancer Nanotechnology encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Cancer Nanotechnology is assigned the following International Standard Serial Numbers (ISSN): 18686958, 18686966.
The best quartile for the Cancer Nanotechnology is Q2 (2023).
The Cancer Nanotechnology coverage history can be summarized as follows: 2010-2023.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Dermatologia Kliniczna | journal | 25442 | Cornetis | 7 | 0.00 |
| Modern Language Journal | journal | 1100 | Wiley-Blackwell | 112 | 3.93 |
| International Journal of Research and Method in Education | journal | 5876 | Taylor and Francis Ltd. | 38 | 2.50 |
| Archives of the Balkan Medical Union | journal | 23592 | Balkan Medical Union | 12 | 0.21 |
| Built Environment | journal | 12809 | Alexandrine Press | 46 | 1.18 |
| Proceedings of the ACM SIGKDD International Conference on Knowledge Discovery and Data Mining | conference and proceedings | 4334 | 192 | 0.00 | |
| European Journal of Wildlife Research | journal | 9693 | Springer Verlag | 59 | 1.76 |
| Transboundary and Emerging Diseases | journal | 5087 | 84 | 3.59 | |
| HOMO- Journal of Comparative Human Biology | journal | 20265 | Elsevier B.V. | 38 | 0.79 |
| Clinical Interventions in Aging | journal | 5314 | Dove Medical Press Ltd. | 104 | 3.55 |
| Year | Impact Score (IS) |
|---|---|
| 2024/2025 | Coming Soon |
| 2023 | 4.21 |
| 2022 | 4.85 |
| 2021 | 7.31 |
| 2020 | 4.86 |
| 2019 | 4.95 |
| 2018 | 5.81 |
| 2017 | 3.29 |
| 2016 | 5.64 |
| 2015 | 1.91 |
| 2014 | 2.00 |
